lainemd.bsky.social
@lainemd.bsky.social
Read what Annals of Internal Medicine is doing to limit the damage to medical research of recent political action www.acpjournals.org/doi/10.7326/...
March 6, 2025 at 3:16 AM
www.acpjournals.org/doi/10.7326/...
RFK jr has said that he wants evidence that MMR vaccination is not linked to autism- here it is, Mr. HHS secretary. By the way, this evidence is not new- was published in 2018.
February 13, 2025 at 5:13 PM
Annals of Internal Medicine

Adverse consequences of abrupt disruption of PEPFAR funding. Annals.org
February 12, 2025 at 9:17 PM
Annals.org From the Annals ‘Spotlight on 2024’ collection: A target trial emulation study found #bupropion was consistently associated with the least weight gain among 8 first-line #antidepressant treatments. bit.ly/4hQ8e9o
Medication-Induced Weight Change Across Common Antidepressant Treatments: A Target Trial Emulation Study: Annals of Internal Medicine: Vol 177, No 8
Background: Antidepressants are among the most commonly prescribed medications, but evidence on comparative weight change for specific first-line treatments is limited. Objective: To compare weight ch...
bit.ly
February 11, 2025 at 1:05 AM
A new issue of Annals is online now. Read about bleeding risk with #apixaban and #dabigatran, results of interventions to reduce overuse of medical care, a new Annals #BeyondtheGuidelines tackles #AFIB, and more. bit.ly/4iXoo26
February 11, 2025 at 1:03 AM
A Calling No Longer? When Medicine Is Redefined as a Job: bit.ly/4gAYbnj
ACP Journals
bit.ly
February 10, 2025 at 6:47 PM
Watch ACP President Isaac O. Opole, MBChB, PhD, MACP discuss ACP's new guidelines for the prevention of episodic migraine. ACP makes three specific recommendations based on two systematic evidence reviews that take into consideration patient preferences and costs. bit.ly/4jQd9Ji
ACP President Discusses New Guidelines for the Prevention of Episodic Migraine
In this guideline, ACP makes recommendations for clinicians to initiate monotherapy for episodic migraine prevention in nonpregnant adults in the outpatient setting as well as alternative approaches if initial treatments are not tolerated or result in an inadequate response.
bit.ly
February 10, 2025 at 6:46 PM
New today: Testing and treating Medicare-eligible persons at risk or latent #tuberculosis infection could lead to substantial reductions in TB and TB-related mortality, particularly among 65-year-olds newly eligible for Medicare. bit.ly/3QaIVTI
Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022 | Annals of Internal Medicine
Background: In the United States, older adults have elevated prevalence of latent tuberculosis infection (LTBI) and incidence of tuberculosis (TB). Objective: To estimate the health benefits and cost-...
bit.ly
February 10, 2025 at 6:45 PM
Annals of Internal Medicine’s specialty collections include research, reviews, and expert opinion on topics ranging from cardiology to prevention efforts. View our specialty collections here: bit.ly/3Z59rBK
February 10, 2025 at 6:44 PM